Interpace Biosciences Inc (NASDAQ:IDXG)

4.08
Delayed Data
As of Oct 23
 +0.375 / +10.12%
Today’s Change
2.57
Today|||52-Week Range
11.00
-18.40%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +181.86% increase from the last price of 4.08.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Interpace Biosciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.30
Sales
$7.6M
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.52%
 
 
 
 
 
 
Growthannually 25.90%
 
 
 
 
 
 

Sales

Growthquarterly 39.74%
 
 
 
 
 
 
Growthannually 29.11%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.